Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kinugasa, E.
Right arrow Articles by Ideura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinugasa, E.
Right arrow Articles by Ideura, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 20-27
© 2002 European Renal Association-European Dialysis and Transplant Association



Effects of 1,25-dihydroxy-22-oxavitamin D3 on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism

Eriko Kinugasa1,, Tadao Akizawa2, Junko Takahashi3, Kunihiro Nabeshima3, Hiroaki Ogata1, Fumiyoshi Nakayama4 and Terukuni Ideura5

1 Department of Internal Medicine, Showa University Northern Yokohama Hospital, Yokohama, Japan, 2 Center of Blood Purification Therapy, Wakayama Medical College, Wakayama, Japan, 3 Eda Clinic, Yokohama, Japan, 4 Dai-ni Eda Clinic, Yokohama, Japan and 5 Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan

Abstract

Secondary hyperparathyroidism (2HPT) is characterized by an abnormal threshold for suppression of parathyroid hormone (PTH) secretion by serum ionized Ca (ICa). It is therefore critical to examine the threshold of PTH secretion in chronic renal failure patients in relation to the physiopathological conditions and the severity of 2HPT. The effect of 1,25-dihidroxy-22-oxavitamin D3 (22-oxacalcitriol, OCT) on parathyroid gland function was investigated in six haemodialysis patients with 2HPT. OCT was administered three times a week for 26 consecutive weeks. The maximum serum PTH (PTHmax), the minimum serum PTH (PTHmin), and ICa concentration required to inhibit 50% of PTHmax were estimated based on the model formula of the sigmoid curve describing the relationship between ICa and intact-PTH levels. The sigmoid ICa–PTH curves displayed a downward shift at 12 and 26 weeks of OCT treatment. Parathyroid gland function, as reflected by both PTHmax and PTHmin, decreased over time. A steep slope was found at 12 and 26 weeks, compared with that at the start of OCT treatment. There were no marked changes in the set point of calcium. Hypercalcaemia and elevated creatine phosphokinase, probably due to OCT therapy, were observed during the study period. In view of the findings that the sigmoid ICa–PTH curve displayed a downward shift, that both PTHmax and PTHmin decreased, and that functional mass of the parathyroid gland was reduced, OCT appears to be useful in ameliorating parathyroid gland function, contributing to the management of 2HPT.

Keywords: haemodialysis; OCT; parathyroid gland function; parathyroid hormone; secondary hyperparathyroidism; set point

Notes

Correspondence and offprint requests to: Eriko Kinugasa, MD, Associate Professor, Department of Internal Medicine, Showa University Northern Yokohama Hospital, 35-1 Chigasaki-chuou, Tsuzuki-ku, Yokohama 224-8503, Japan. Email: kinugasa{at}med.showa\|[hyphen]\|u.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.